Navigation Links
Reliance Group to Develop Specialty Blood Products

New Delhi: Reliance Life Sciences, the biotechnology venture of Mukesh Ambani's Reliance Group, is developing specialty plasma proteins or blood products and building// a world class manufacturing unit to produce them.

It has been encouraged to set up a manufacturing unit due to the response to its Factor VII product, which is proving a boon for hemophiliacs who have deficiency of Factor VII in their blood that leads to serious blood clotting disorders.

"Encouraged by the market response, we are now developing specialty plasma proteins as well as building a large scale plasma protein manufacturing facility," K.V. Subramaniam, president and CEO of Reliance Life Sciences said in a statement Monday.

Plasma is the storage and transport medium of clotting factors. Its protein content is necessary to maintain the oncotic pressure of the blood, which 'holds' the serum within the vessels.

Until recently plasma proteins including Factor VII were mostly being imported.

Reliance Life Sciences is now meeting this demand through indigenous research and development.

It is manufacturing many of the plasma proteins - Albumin, Intravenous Immunoglobulin G, Factor VII, Fibrin sealant and Virus inactivated plasma - in its pilot scale facility in Mumbai.

The new facility is expected to be operational in the second half of 2007, said Subramaniam.

On Nov 29, a hemophiliac patient was able to undergo a total knee replacement at a hospital in the capital using 40,000 international units of Factor VII manufactured by Reliance Life Sciences, he said.

The availability of indigenously manufactured plasma protein, particularly Factor VII which was earlier totally imported, has helped patients due to the lower prices, and also removed uncertainty in supplies and the short expiry of imported products.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. New Infertility test to be offered by Reliance
2. Reliance Infocomm Tied With Apollo To Provide Telemedicine Services
3. Suicide risk high in 12-17 Age Group
4. Wockhardt Group Plans Hospital In Delhi By End-2007
5. Group Suicides On The Rise In Japan
6. Yogic Moments: Age Old Yoga, Benefits All Age Groups
7. Group Jogging More Beneficial To Health Than Solo Jogging
8. Plastic Surgery Is Primetime among Ethnic Groups
9. Study Finds Online Support Groups Emotionally Benefit Women Suffering From
10. Specialist Services Can Help Ethnic Groups To Tackle Alcohol Misuse
11. Distinct Support Services Needed, To Resurrect Ethnic Groups from Alcohol Abuse
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... June 23, 2017 , ... PureLife Dental is pleased ... separator supplier for CDA members. As part of the amalgam separator endorsement, all CDA ... saving more than $400 off the retail value. This partnership between PureLife and CDA ...
(Date:6/23/2017)... ... 2017 , ... Ulster University, Magee Campus in Northern Ireland is hosting The ... to present to graduate students exciting new and innovative hope research based on iFred’s ... The Health Improvement Service of the Western Health & Social Care Trust (WHSCT) in ...
(Date:6/23/2017)... ... June 23, 2017 , ... All-Star Insurance, a family managed agency that offers ... Texas, is announcing the launch of a new charity drive to benefit women in ... United States reveal that an estimated 252, 710 new cases of invasive or high ...
(Date:6/22/2017)... ... ... Branches, Inc. has been partnering with The Miami Foundation for over 9 ... focused on providing opportunity to low-income families and breaking the cycle of generational poverty. ... to support its , Climb to College & Career initiative which focuses on postsecondary ...
(Date:6/22/2017)... ... June 22, 2017 , ... Groove Ring is excited ... about their high performance silicon wedding bands and all-purpose rings. Whether you’re an athlete, ... silicone rings designed just for you. , From the rock face to the auto ...
Breaking Medicine News(10 mins):
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... Israel, May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... technology which enables the functional selection of stem cells, ... for the first quarter ended March 31 st , ... our accomplishments in the first quarter of 2017," said ... quarter, we announced the treatment of the first blood ...
(Date:5/22/2017)... VALLEY COTTAGE, N.Y. , May 22, 2017 ... natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of ... in plain English, the results of a clinical ... after one year treatment with Gene-Eden-VIR/Novirin in individuals ... is important to note that there are no ...
Breaking Medicine Technology: